Evolution of IL-23 Blockade in Inflammatory Bowel Disease

被引：2
|
作者：
Danese, Silvio [1 ,2 ]
Peyrin-Biroulet, Laurent [3 ,4 ]
机构：
[1] IRCCS San Raffaele, Gastroenterol & Endoscopy, Via Olgettina 60, I-20132 Milan, Italy
[2] Univ Vita Salute, Via Olgettina 60, I-20132 Milan, Italy
[3] Lorraine Univ, Dept Hepato Gastroenterol, Vandoeuvre Les Nancy, France
[4] Lorraine Univ, INSERM, U1256, Univ Hosp Nancy, Vandoeuvre Les Nancy, France
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷 / SUPPL 2期
关键词：
IBD;
D O I：
10.1093/ecco-jcc/jjab188
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
    De Nitto, Daniela
    Sarra, Massimiliano
    Cupi, Maria Laura
    Pallone, Francesco
    Monteleone, Giovanni
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (33) : 3656 - 3660
  • [32] Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
    Fitzpatrick, Leo R.
    INTERNATIONAL JOURNAL OF INFLAMMATION, 2012, 2012
  • [33] Modeling the Distinct Roles for IL-23 and IL-17 in Inflammatory Bowel Disease Using Mdr1a-/- Mice
    Maxwell, Joe
    Brown, William
    Zhang, Yu
    Rottman, James B.
    Budelsky, Alison
    Towne, Jennifer
    GASTROENTEROLOGY, 2013, 144 (05) : S806 - S806
  • [34] THE ADMINISTRATION OF TRICHURIS SUIS OVA EXTRACT DECREASES IL-17/IL-23 LEVELS IN EXPERIMENTAL INFLAMMATORY BOWEL DISEASE
    Catana, Cristina-Sorina
    Magdas, Cristian
    Budisan, Liviuta
    Craciun, Elena-Cristina
    Tabaran, Flaviu
    Deak, Georgiana
    Magdas, Virginia Ana
    Pestean, Cosmin
    Ober, Ciprian
    Berindan-Neagoe, Ioana
    Cozma, Vasile
    Cozma-Petrut, Anamaria
    Dumitrascu, Dan Lucian
    FARMACIA, 2018, 66 (06) : 1021 - 1027
  • [35] Lactic Acid Bacteria with Concomitant IL-17, IL-23 and TNFα- Binding Ability for the Treatment of Inflammatory Bowel Disease
    Kosler, Stasa
    Strukelj, Borut
    Berlec, Ales
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (04) : 318 - 326
  • [36] Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel disease
    Cairns, J.
    Monkley, S.
    Tian, S.
    Angermann, B.
    Liu, Z.
    Oberg, L.
    Muthas, D.
    Cabrera, C.
    Rapsomaniki, E.
    Llaneza, D. Fernandez
    Olsson, M.
    Paraskos, J.
    Ellison, G.
    Khan, E.
    Duncan, E. A.
    Neisen, J.
    Gehrmann, U.
    Chamberlain, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I64 - I67
  • [37] Molecular regulation of IL-23 p19 gene expression in macrophages and murine inflammatory bowel disease
    Sheikh, Shehzad
    Matsuoka, Katsuyoshi
    Li, Fengling
    Plevy, Scott
    CLINICAL IMMUNOLOGY, 2008, 127 : S119 - S119
  • [38] The mode of action of IL-23 in experimental inflammatory arthritic pain and disease
    Lee, Kevin M. -C.
    Lupancu, Tanya
    Chang, Leon
    Manthey, Carl L.
    Zeeman, Martha
    Fourie, Anne M.
    Hamilton, John A.
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [39] IL-23 promotes arthritic and inflammatory pain
    Jessica McHugh
    Nature Reviews Rheumatology, 2020, 16 : 409 - 409
  • [40] IL-23 promotes arthritic and inflammatory pain
    McHugh, Jessica
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (08) : 409 - 409
12345